You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 28, 2024

DSUVIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dsuvia, and what generic alternatives are available?

Dsuvia is a drug marketed by Vertical Pharms and is included in one NDA. There are twenty patents protecting this drug.

This drug has one hundred and five patent family members in twenty countries.

The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dsuvia

A generic version of DSUVIA was approved as sufentanil citrate by HIKMA on December 15th, 1995.

  Sign Up

Summary for DSUVIA
Drug patent expirations by year for DSUVIA
Drug Prices for DSUVIA

See drug prices for DSUVIA

Recent Clinical Trials for DSUVIA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Frank GuyettePhase 3
United States Department of DefensePhase 3
Montefiore Medical CenterPhase 4

See all DSUVIA clinical trials

Pharmacology for DSUVIA
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Anatomical Therapeutic Chemical (ATC) Classes for DSUVIA

US Patents and Regulatory Information for DSUVIA

DSUVIA is protected by twenty US patents.

Patents protecting DSUVIA

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Small-volume oral transmucosal dosage forms
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DSUVIA

See the table below for patents covering DSUVIA around the world.

Country Patent Number Title Estimated Expiration
China 101394863 Small-volume oral transmucosal dosage forms ⤷  Sign Up
Denmark 3682915 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2007081949 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DSUVIA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2114383 CR 2016 00007 Denmark ⤷  Sign Up PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922
2114383 300797 Netherlands ⤷  Sign Up PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922
2114383 16C0010 France ⤷  Sign Up PRODUCT NAME: SUFENTANIL; REGISTRATION NO/DATE: EU/1/15/1042 20150918
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.